The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
10-(3-[N-diethanolamino]propyl)-2,4-dimethylacridone ID: ALA4096764
PubChem CID: 137653396
Max Phase: Preclinical
Molecular Formula: C22H28N2O3
Molecular Weight: 368.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)c2c(c1)c(=O)c1ccccc1n2CCCN(CCO)CCO
Standard InChI: InChI=1S/C22H28N2O3/c1-16-14-17(2)21-19(15-16)22(27)18-6-3-4-7-20(18)24(21)9-5-8-23(10-12-25)11-13-26/h3-4,6-7,14-15,25-26H,5,8-13H2,1-2H3
Standard InChI Key: OJXGDCVVEXNSPG-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
14.9649 -19.9717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9649 -18.3373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6701 -18.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6685 -19.5654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3728 -19.9727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0791 -19.5657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0767 -18.7472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3719 -18.3436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2596 -19.5672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2621 -18.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5584 -18.3437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8516 -18.7499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8530 -19.5683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5573 -19.9728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9634 -17.5201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.3721 -20.7899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7831 -18.3364 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9660 -20.7889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2589 -21.1985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2601 -22.0157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5530 -22.4253 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8464 -22.0174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1414 -22.4236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8465 -23.6509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5577 -23.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4340 -22.0143 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8441 -24.4681 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
9 1 1 0
1 4 1 0
3 2 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 3 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
2 15 2 0
5 16 1 0
7 17 1 0
1 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 25 1 0
22 23 1 0
24 25 1 0
23 26 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 368.48Molecular Weight (Monoisotopic): 368.2100AlogP: 2.45#Rotatable Bonds: 8Polar Surface Area: 65.70Molecular Species: BASEHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.56CX LogP: 2.85CX LogD: 1.66Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.60Np Likeness Score: -0.83
References 1. Murahari M, Kharkar PS, Lonikar N, Mayur YC.. (2017) Design, synthesis, biological evaluation, molecular docking and QSAR studies of 2,4-dimethylacridones as anticancer agents., 130 [PMID:28246041 ] [10.1016/j.ejmech.2017.02.022 ]